Linked Data API

Show Search Form

Search Results

1697134
registered interest false more like this
date less than 2024-03-19more like thismore than 2024-03-19
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hospitals: Older People more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many hospital admissions for patients aged 65 and over were the result of a fall in 2012-13. more like this
tabling member constituency Bristol South more like this
tabling member printed
Karin Smyth more like this
uin 19386 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2024-03-22
answer text <p>NHS England published information on finished consultant episodes for admitted patients in 2012/13, which is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/hospital-episode-statistics-admitted-patient-care-england-2012-13" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/hospital-episode-statistics-admitted-patient-care-england-2012-13</a></p><p>This shows in 2012/13, there were 283,794 finished consultant episodes relating to a fall, where the patient was 65 years old or over.</p> more like this
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
question first answered
less than 2024-03-22T11:55:43.127Zmore like thismore than 2024-03-22T11:55:43.127Z
answering member
4527
label Biography information for Helen Whately more like this
tabling member
4444
label Biography information for Karin Smyth more like this
1696609
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Autism and Learning Disability: Community Care more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 February 2024 to Question 15040 on Autism and Learning Disability: Community Care, whether the funding flows task and finish group have developed plans to (a) fund support effectively across the health and social care system and (b) improve oversight of expenditure on the Building the Right Support Action Plan. more like this
tabling member constituency Worsley and Eccles South more like this
tabling member printed
Barbara Keeley more like this
uin 19025 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>The aim of the Funding Flows task and finish group was to look at how to improve national oversight of the National Health Service and local authority spend on services and support for people with a learning disability and autistic people who are, or are at risk of being, admitted to mental health inpatient services.</p><p>The Funding Flows task and finish group has been looking at relevant data currently collected for the NHS and local government, to explore whether it could be brought together to help meet this objective. The final report from the Funding Flows task and finish group will be shared with the Building the Right Support Delivery Board in due course.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2024-03-21T12:09:57.897Zmore like thismore than 2024-03-21T12:09:57.897Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
1588
label Biography information for Barbara Keeley more like this
1696620
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Electronic Cigarettes: Retail Trade more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether her Department has had discussions with the UK Vaping Industry Association on its proposals for a vape retail licence. more like this
tabling member constituency Windsor more like this
tabling member printed
Adam Afriyie more like this
uin 19019 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>The Department has not had any discussions with the UK Vaping Industry Association on its proposals for a vape retail license, though we have received written representations on this issue. There are no current plans to introduce a licensing scheme. However, the Government recognises that strong enforcement is needed to tackle underage and illicit vape sales. The new Tobacco and Vapes Bill includes provisions to issue fixed penalty notices for underage tobacco and vape sales. This will complement existing powers that local authorities have to enforce age of sale legislation including fines of up to £2,500, and for the most serious offences, court orders to prevent the offending retailer from opening for a period.</p><p>In addition, we have committed to increasing investment for our enforcement agencies by £30 million per year, and at Spring Budget the Chancellor announced that the Government will introduce a new duty on vaping products, giving HM Revenue and Customs further powers to minimise fraud, introduce civil and criminal powers to seize illicit products and equipment, and issue penalties.</p>
answering member constituency South Northamptonshire more like this
answering member printed Andrea Leadsom more like this
question first answered
less than 2024-03-21T11:15:54.43Zmore like thismore than 2024-03-21T11:15:54.43Z
answering member
4117
label Biography information for Andrea Leadsom more like this
tabling member
1586
label Biography information for Adam Afriyie more like this
1696623
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Audiology: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce waiting times for hospital hearing (a) tests and (b) aid fitting in areas where no community audiology service is commissioned. more like this
tabling member constituency Bolton South East more like this
tabling member printed
Yasmin Qureshi more like this
uin 19029 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>Audiology services are locally commissioned by the 42 integrated care boards (ICBs) across England. Waiting times for audiology assessments are recorded through the national diagnostic activity and waiting times collection. This data is reviewed and monitored monthly across the ICBs and NHS England.</p><p>NHS England has been working to enable improvement in access to audiology services including through developing an improvement guide, endorsed by the British Audiology Association, which outlines approaches the ICBs can take to address waiting times. NHS England’s National Diagnostics programme has supported implementation of this guide through a series of webinars and case studies to share learning.</p> more like this
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
question first answered
less than 2024-03-21T12:06:26.82Zmore like thismore than 2024-03-21T12:06:26.82Z
answering member
4527
label Biography information for Helen Whately more like this
tabling member
3924
label Biography information for Yasmin Qureshi more like this
1696697
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Skin Diseases: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if she will make an assessment of the effectiveness of drugs available within the NHS to treat (a) epidermolysis bullosa and (b) other inflammatory skin conditions. more like this
tabling member constituency Christchurch more like this
tabling member printed
Sir Christopher Chope more like this
uin 18966 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>The National Institute for Health and Care Excellence (NICE) makes independent, evidence-based recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits.</p><p>Currently, there is one product licensed specifically for epidermolysis bullosa, Filsuvez gel, which contains birch bark extract. The NICE recommends birch bark extract as a clinically and cost effective use of NHS resources, and the NHS is legally required to fund it in line with the NICE’s recommendations. Other healthcare products are also used in the care of epidermolysis bullosa patients. There are a number of licensed and NICE recommended treatments for other inflammatory skin conditions that are now routinely available for NHS patients.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-03-21T12:21:44.79Zmore like thismore than 2024-03-21T12:21:44.79Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
242
label Biography information for Sir Christopher Chope more like this
1696698
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Trastuzumab Deruxtecan more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the decision by the National Institute for Health and Care Excellence to not recommend trastuzumab deruxtecan for HER2-low secondary breast cancer for use on NHS on the life expectancy of eligible women. more like this
tabling member constituency North Warwickshire more like this
tabling member printed
Craig Tracey more like this
uin 19119 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet published final guidance on the use of trastuzumab deruxtecan (Enhertu) for the treatment of metastatic HER2-low breast cancer. The NICE published final draft guidance on 5 March 2024, that does not recommend it as a clinically and cost-effective use of National Health Service resources. Stakeholders had until 19 March 2024 to lodge an appeal against the NICE’s recommendations. The NICE currently expects to publish final guidance on 3 April 2024.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-03-21T17:10:39.977Zmore like thismore than 2024-03-21T17:10:39.977Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4509
label Biography information for Craig Tracey more like this
1696701
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood: Contamination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the number of people who were (a) treated with contaminated blood products and (b) given contaminated blood transfusions by the NHS in Morely and Outwood constituency. more like this
tabling member constituency Morley and Outwood more like this
tabling member printed
Dame Andrea Jenkyns more like this
uin 19112 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>The Department has not made an estimate of the number of people who were treated with contaminated blood products and given contaminated blood transfusions by the National Health Service in the Morely and Outwood constituency.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2024-03-21T12:11:19.7Zmore like thismore than 2024-03-21T12:11:19.7Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4490
label Biography information for Dame Andrea Jenkyns more like this
1696702
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Blood: Contamination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the number of people who have died since being (a) treated with contaminated blood products and (b) given contaminated blood transfusions in Morley and Outwood constituency. more like this
tabling member constituency Morley and Outwood more like this
tabling member printed
Dame Andrea Jenkyns more like this
uin 19113 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2024-03-22
answer text <p>The Department has not made an estimate of the number of people who have died since being treated with contaminated blood products and given contaminated blood transfusions, in the Morley and Outwood constituency.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2024-03-22T15:33:52.49Zmore like thismore than 2024-03-22T15:33:52.49Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4490
label Biography information for Dame Andrea Jenkyns more like this
1696710
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Life Expectancy more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential long-term impact of the cost of living on life expectancy; and what steps her Department is taking to reduce regional disparities in life expectancy. more like this
tabling member constituency Preston more like this
tabling member printed
Sir Mark Hendrick more like this
uin 18981 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-21more like thismore than 2024-03-21
answer text <p>The Government is mindful of potential interactions between cost of living pressures and health, which is one of the reasons we are delivering cost of living support worth an average of £3,700 per household between 2022 and 2025. The Government is committed to its levelling up mission to narrow the gap in healthy life expectancy by 2030, and increase healthy life expectancy by five years by 2035.</p><p>In January 2023 we announced our plan to publish the Major Conditions Strategy. The strategy will be a direction setting document which aims to pave the way for further action towards integrated care, coordinated around the needs of people, to address our aims of improving healthy life expectancy, reduce pressure on the National Health Service, and reduce ill-health related labour market inactivity. It will emphasise the importance of working with local services and organisations to address disparities in health outcomes, supporting the levelling up mission. Our intention is to publish the Major Conditions Strategy in Spring 2024.</p>
answering member constituency South Northamptonshire more like this
answering member printed Andrea Leadsom more like this
question first answered
less than 2024-03-21T15:38:32.703Zmore like thismore than 2024-03-21T15:38:32.703Z
answering member
4117
label Biography information for Andrea Leadsom more like this
tabling member
473
label Biography information for Sir Mark Hendrick more like this
1696715
registered interest false more like this
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Sodium Valproate: Compensation more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published on 7 February 2024, if she will make an assessment of the potential merits of providing interim payments to victims of sodium valproate. more like this
tabling member constituency Lancaster and Fleetwood more like this
tabling member printed
Cat Smith more like this
uin 19086 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-20more like thismore than 2024-03-20
answer text <p>The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2024-03-20T14:58:00.727Zmore like thismore than 2024-03-20T14:58:00.727Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4436
label Biography information for Cat Smith more like this